PubMed · 1990 · 32 citations · 0 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyCell SignalingSignal TransductionBioactive Small MoleculesEnzyme InhibitionGrowth Factor SignalingReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsEpidermal Growth Factor Receptor EndocytosisEpidermal Growth Factor Receptor InhibitionEpidermal Growth Factor Receptor SignalingPhosphatidylinositol 3-Kinase PathwayPhosphatidylinositol 3-Kinase-akt PathwaySmall Molecule Tyrosine Kinase InhibitorsTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase Inhibition
Lavendustin A is a novel microbial secondary metabolite that strongly inhibits tyrosine kinase in vitro. But, since it was found that it did not inhibit tyrosine kinase in situ, possibly because of its poor penetration into the cells, the authors therefore synthesized a methyl ester derivative of lavendustin A. Lavendustin A methyl ester inhibited autophosphorylation and internalization of epidermal growth factor receptor in cultured A431 cells. It also inhibited phosphatidylinositol kinase in vitro and phosphatidylinositol turnover in situ.